Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02616588
Other study ID # 15-2137
Secondary ID
Status Completed
Phase N/A
First received November 20, 2015
Last updated May 9, 2017
Start date February 2016
Est. completion date April 2017

Study information

Verified date May 2017
Source VA Eastern Colorado Health Care System
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall goal of this study is to evaluate the feasibility of a veteran patient navigator and social work counseling intervention in veterans with advanced stage cancer at the Denver VA Medical Center. This is a tiered intervention: patients first receive the veteran patient navigator component of the intervention, and then if additional patient needs are present they receive the social work counseling component of the intervention. The overall intervention will help veterans communicate their care preferences with their providers.This is a study of behavioral and care strategy interventions and involves no investigational drugs or devices.


Description:

Many patients with advanced cancer suffer from multiple symptoms including pain and fatigue and high rates of depression and anxiety. Many also experience end of life care that is inconsistent with their preferences.

Recent studies of palliative care find that symptoms, depression, and end of life care quality improved in patients with advanced cancer with multidisciplinary, specialist palliative care compared to usual care. However, these palliative care interventions are personnel-intensive and require multiple specialist providers. Because of the costs and limited availability of specialist palliative care providers, these interventions cannot be spread to the large population of patients with advanced cancer. Thus, there is a need for scalable interventions to improve symptoms, depression, and end of life care in this patient population.

Patient navigators, who often belong to the community they serve, have improved rates of cancer screening, follow up on abnormal diagnostic tests, and adherence to chemotherapy regimens. There has been increasing recognition that palliative care is an important part of patient navigation. However, to the best of our knowledge, there have been no studies outside our research program that have examined the effects of a peer navigation intervention to improve palliative care outcomes.

While patient navigators hold promise for improving outcomes in patients with advanced cancer, both psychosocial care needs and documenting future care preferences and goals may be complex. Therefore, the proposed intervention will supplement veteran patient navigators with a social work psychosocial intervention. The goal of the proposed study is to evaluate the feasibility of a stepped care intervention including a veteran patient navigator and social worker.


Recruitment information / eligibility

Status Completed
Enrollment 17
Est. completion date April 2017
Est. primary completion date April 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 108 Years
Eligibility Inclusion Criteria:

- Adult (over 18 years of age)

- Patient has an oncology provider within the VA ECHCS

- English is patient's primary language

- Has a reliable telephone

- Diagnosis of cancer deemed as incurable by oncology provider

- Oncology provider answers "no" to the question, "Would you be surprised if this patient dies in the next year?"

Exclusion Criteria:

- Already receiving specialist palliative care or receiving hospice care

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Veteran Patient Navigator and Social Work Intervention
Each study participant will receive a veteran patient navigator intervention which consists of five study visits consisting of advance care planning, pain/symptom management, and education about hospice and palliative care. When clinically indicated, patients will be referred to a social work intervention providing psychosocial care and support.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
VA Eastern Colorado Health Care System

References & Publications (14)

Arrieta O, Angulo LP, Núñez-Valencia C, Dorantes-Gallareta Y, Macedo EO, Martínez-López D, Alvarado S, Corona-Cruz JF, Oñate-Ocaña LF. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol. 2013 Jun;20(6):1941-8. doi: 10.1245/s10434-012-2793-5. Epub 2012 Dec 22. — View Citation

Block SD, Billings JA. A need for scalable outpatient palliative care interventions. Lancet. 2014 May 17;383(9930):1699-700. doi: 10.1016/S0140-6736(13)62676-8. Epub 2014 Feb 19. — View Citation

Calhoun EA, Whitley EM, Esparza A, Ness E, Greene A, Garcia R, Valverde PA. A national patient navigator training program. Health Promot Pract. 2010 Mar;11(2):205-15. doi: 10.1177/1524839908323521. Epub 2008 Dec 30. — View Citation

Fischer SM, Cervantes L, Fink RM, Kutner JS. Apoyo con Cariño: a pilot randomized controlled trial of a patient navigator intervention to improve palliative care outcomes for Latinos with serious illness. J Pain Symptom Manage. 2015 Apr;49(4):657-65. doi: 10.1016/j.jpainsymman.2014.08.011. Epub 2014 Sep 18. — View Citation

Freeman HP, Chu KC. Determinants of cancer disparities: barriers to cancer screening, diagnosis, and treatment. Surg Oncol Clin N Am. 2005 Oct;14(4):655-69, v. Review. — View Citation

Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract. 1995 Jan-Feb;3(1):19-30. — View Citation

Freeman HP. Patient navigation: a community based strategy to reduce cancer disparities. J Urban Health. 2006 Mar;83(2):139-41. — View Citation

Freeman HP. Patient navigation: a community centered approach to reducing cancer mortality. J Cancer Educ. 2006 Spring;21(1 Suppl):S11-4. — View Citation

Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG. End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol. 2010 Mar 1;28(7):1203-8. doi: 10.1200/JCO.2009.25.4672. Epub 2010 Feb 1. — View Citation

Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. — View Citation

Steinberg ML, Fremont A, Khan DC, Huang D, Knapp H, Karaman D, Forge N, Andre K, Chaiken LM, Streeter OE Jr. Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges. Cancer. 2006 Dec 1;107(11):2669-77. — View Citation

Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678. — View Citation

Wells KJ, Battaglia TA, Dudley DJ, Garcia R, Greene A, Calhoun E, Mandelblatt JS, Paskett ED, Raich PC; Patient Navigation Research Program.. Patient navigation: state of the art or is it science? Cancer. 2008 Oct 15;113(8):1999-2010. doi: 10.1002/cncr.23815. Review. — View Citation

Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014 May 17;383(9930):1721-30. doi: 10.1016/S0140-6736(13)62416-2. Epub 2014 Feb 19. — View Citation

* Note: There are 14 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Aim 1A. Examine intervention feasibility. The intervention will be feasible if:
A. The participation rate is above 40% and the retention rate is above 60%.
1 year
Primary Aim 1B. Examine intervention feasibility. The intervention will be feasible if:
B. Oncology providers and patient participants find the intervention acceptable as defined by mean ratings of above "somewhat" useful/helpful/satisfied (i.e., above 3 on a 1 to 5 Likert scale, where 5 is "extremely" and 1 is "not at all."
1 year
Primary Aim 1C. Examine intervention feasibility. The intervention will be feasible if:
C. There is less than 10% missing data on patient-reported survey measures.
1 year
Secondary Aim 2A. aTrack intervention process in order to improve the intervention A. Determine patient flow through the intervention and adherence to the study protocol by tracking:
a. number of visits
1 year
Secondary Aim 2Ab. Track intervention process in order to improve the intervention A. Determine patient flow through the intervention and adherence to the study protocol by tracking:
b. visit length
1 year
Secondary Aim 2Ac. Track intervention process in order to improve the intervention A. Determine patient flow through the intervention and adherence to the study protocol by tracking:
c problem addressed
1 year
Secondary Aim 2Ad. Track intervention process in order to improve the intervention A. Determine patient flow through the intervention and adherence to the study protocol by tracking:
d. who is seen by the social worker and why
1 year
Secondary Aim 2Ae. Track intervention process in order to improve the intervention A. Determine patient flow through the intervention and adherence to the study protocol by tracking:
e. adherence to the study protocol
1 year
Secondary Aim 2B. Track intervention process in order to improve the intervention B. Understand patient and oncology provider reactions through qualitative interviews to the intervention to inform how to improve feasibility or helpfulness. 1 year
See also
  Status Clinical Trial Phase
Completed NCT01706627 - Melatonin In Reduction of Chemotherapy-Induced Toxicity (MIRCIT) Trial Phase 2/Phase 3